Dehaier Extends Exclusive Distribution Authorization With Timesco


BEIJING, Feb. 18, 2014 (GLOBE NEWSWIRE) -- Dehaier Medical Systems Ltd. (Nasdaq:DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it received the exclusive distribution right renewal from Timesco in related to CLX laryngoscope products. Pursuant to the renewal agreement, Dehaier will continue to have the exclusive right to direct sale, distribute and bid of optima range products, including CLX and Eclipse blades and handles in mainland China through 2014.

Dehaier's President and CEO, Mr. Ping Chen, stated, "Since we have initiated our cooperation with Timesco in 2003, as its exclusive distributor in China, we have been maintaining a sound partnership with Timesco. The CLX series products offer broad visual field and better vision upon its patented light source, fulfill all sorts of demands of clinical demands through diversified models and specifications, which can be recognized as one of the most widely-used laryngoscopes in China. CLX Laryngoscope series is one of our flagship products which have a quite stable, significant market share and for a long time ranked within top three in China. Dealers and consumers respond very well and Dehaier has occupied competitive leadership in the market of laryngoscope. Going forward, we will continue to build out our distribution network and the agent platform for our ever growing medical device products."

About Timesco

Founded in 1964, Timesco of London is a medical supplies company that designs, manufactures, and sells surgical and non-surgical medical and dental instruments. Its specialties include products for laryngoscope, surgery, podiatry, and primary care as well as emergency health care, midwifery, and more. The Company has been recognized as one of the most progressive surgical and medical companies in the U.K. Their goal is to serve the healthcare needs of all consumers in all cultures throughout the world. To develop new, innovative medical technologies that will save or improve the quality of life, whilst meeting the highest standards of quality and product safety at all times.

About Dehaier Medical Systems Ltd.

Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), Welch Allyn (USA), HEYER (Germany), Timesco (UK), eVent Medical (US) and JMS (Japan). Dehaier's technology is based on six patents, ten software copyrights and proprietary technology. More information may be found at http://www.dehaier.com.cn

Forward-looking Statements

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, fulfillment of bids and contracts, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.



            

Contact Data